Gene connectivity and enzyme evolution in the human metabolic network

Abstract

Background: Determining the factors involved in the likelihood of a gene being under adaptive selection is still a challenging goal in Evolutionary Biology. Here, we perform an evolutionary analysis of the human metabolic genes to explore the associations between network structure and the presence and strength of natural selection in the genes whose products are involved in metabolism. Purifying and positive selection are estimated at interspecific (among mammals) and intraspecific (among human populations) levels, and the connections between enzymatic reactions are differentiated between incoming (in-degree) and outgoing (out-degree) links. Results: We confirm that purifying selection has been stronger in highly connected genes. Long-term positive selection has targeted poorly connected enzymes, whereas short-term positive selection has targeted different enzymes depending on whether the selective sweep has reached fixation in the population: genes under a complete selective sweep are poorly connected, whereas those under an incomplete selective sweep have high outdegree connectivity. The last steps of pathways are more conserved due to stronger purifying selection, with long-term positive selection targeting preferentially enzymes that catalyze the first steps. However, short-term positive selection has targeted enzymes that catalyze the last steps in the metabolic network. Strong signals of positive selection have been found for metabolic processes involved in lipid transport and membrane fluidity and permeability. Conclusions: Our analysis highlights the importance of analyzing the same biological system at different evolutionary timescales to understand the evolution of metabolic genes and of distinguishing between incoming and outgoing links in a metabolic network. Short-term positive selection has targeted enzymes with a different connectivity profile depending on the completeness of the selective sweep, while long-term positive selection has targeted genes with fewer connections that code for enzymes that catalyze the first steps in the network. Reviewers: This article was reviewed by Diamantis Sellis and Brandon Invergo.

The ZNF750–RAC1 axis as potential prognostic factor for breast cancer

“…In the last decade, OMICS technologies have contributed to our understanding of the pathogenesis of cancer [27][28][29][30] leading to the development of precision oncology 31,32 , where selection of the patients for treatment is fundamental for better therapy outcome 33 . Therefore, identification of novel biomarkers for guiding treatment selection is a key requirement 14,[34][35][36] .…”

Liquid biopsies and cancer omics

“…Great advances in the sequencing technologies are at the roots of the generation of many more accurate molecular data from single cancer specimens. Whole cancer genomes analysis can now be performed at relatively low costs, together with many other "omics", such as whole transcriptomic or proteomic (which can also be further completed by phospho-proteomics, giving a wide picture on the activation of signaling pathways) [15][16][17][18][19][20][21][22][23][24] . These techniques led to the generation of vast amounts of data derived from a single cancer specimen (a diagnostic biopsy or a surgical removal of the disease), therefore determining a molecular deep characterization of a single cancer in a precise and limited time of the disease.…”

Genetic Variants in Transcription Factor Binding Sites in Humans: Triggered by Natural Selection and Triggers of Diseases

“…Interestingly, previous studies suggest that there is some selection pressure in these comorbidities (body mass index [82], chronic kidney disease [83], diabetes [84], altered LDL/HDL/triglyceride levels [74,85], coronary artery disease/ischemic heart disease [86], hypertension [87], hyperuricemia [74], osteoporosis [88], and prostate cancer [89]) related to gout [74]. Accordingly, in the following section we focus on examples of mechanistic investigations of the regulatory elements of TFBSs related to transcription factors, affected genes, and disease phenotypes in gout and its associated comorbidities which exhibit selection signatures in susceptibility loci.…”

“…Gout is associated with an altered lipid profile [75], and risk loci associated with the levels of LDL, HDL, and triglycerides show evident natural selection signatures [74,85]. Several studies have provided evidence for the effects of TFBS variants on lipid metabolism.…”